Pharma & Healthcare

Global AI in Biopharma Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for AI in Biopharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI in Biopharma.
The AI in Biopharma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI in Biopharma market comprehensively. Regional market sizes, concerning products by Type, by Application, by Research Direction and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI in Biopharma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Recursion Pharmaceuticals
Exscientia
XtalPi
Schrödinger
Owkin
Evogene
BioNTech
MedySapiens
Segment by Type
Machine Learning (ML) & Deep Learning (DL)
Natural Language Processing (NLP)
Others
Segment by Research Direction
Drug Discovery & Development
Genomics & Precision Medicine
Medical Imaging & Diagnostics
Others
Segment by Application
Drug Development
Disease Diagnosis and Treatment
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Research Direction etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI in Biopharma company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI in Biopharma Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Machine Learning (ML) & Deep Learning (DL)
1.2.3 Natural Language Processing (NLP)
1.2.4 Others
1.3 Market by Research Direction
1.3.1 Global AI in Biopharma Market Size Growth Rate by Research Direction: 2020 VS 2024 VS 2031
1.3.2 Drug Discovery & Development
1.3.3 Genomics & Precision Medicine
1.3.4 Medical Imaging & Diagnostics
1.3.5 Others
1.4 Market by Application
1.4.1 Global AI in Biopharma Market Growth by Application: 2020 VS 2024 VS 2031
1.4.2 Drug Development
1.4.3 Disease Diagnosis and Treatment
1.4.4 Other
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global AI in Biopharma Market Perspective (2020-2031)
2.2 Global AI in Biopharma Growth Trends by Region
2.2.1 Global AI in Biopharma Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI in Biopharma Historic Market Size by Region (2020-2025)
2.2.3 AI in Biopharma Forecasted Market Size by Region (2026-2031)
2.3 AI in Biopharma Market Dynamics
2.3.1 AI in Biopharma Industry Trends
2.3.2 AI in Biopharma Market Drivers
2.3.3 AI in Biopharma Market Challenges
2.3.4 AI in Biopharma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI in Biopharma Players by Revenue
3.1.1 Global Top AI in Biopharma Players by Revenue (2020-2025)
3.1.2 Global AI in Biopharma Revenue Market Share by Players (2020-2025)
3.2 Global Top AI in Biopharma Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI in Biopharma Revenue
3.4 Global AI in Biopharma Market Concentration Ratio
3.4.1 Global AI in Biopharma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI in Biopharma Revenue in 2024
3.5 Global Key Players of AI in Biopharma Head office and Area Served
3.6 Global Key Players of AI in Biopharma, Product and Application
3.7 Global Key Players of AI in Biopharma, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI in Biopharma Breakdown Data by Type
4.1 Global AI in Biopharma Historic Market Size by Type (2020-2025)
4.2 Global AI in Biopharma Forecasted Market Size by Type (2026-2031)
5 AI in Biopharma Breakdown Data by Application
5.1 Global AI in Biopharma Historic Market Size by Application (2020-2025)
5.2 Global AI in Biopharma Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI in Biopharma Market Size (2020-2031)
6.2 North America AI in Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI in Biopharma Market Size by Country (2020-2025)
6.4 North America AI in Biopharma Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI in Biopharma Market Size (2020-2031)
7.2 Europe AI in Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI in Biopharma Market Size by Country (2020-2025)
7.4 Europe AI in Biopharma Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific AI in Biopharma Market Size (2020-2031)
8.2 Asia-Pacific AI in Biopharma Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI in Biopharma Market Size by Region (2020-2025)
8.4 Asia-Pacific AI in Biopharma Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America AI in Biopharma Market Size (2020-2031)
9.2 Latin America AI in Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI in Biopharma Market Size by Country (2020-2025)
9.4 Latin America AI in Biopharma Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI in Biopharma Market Size (2020-2031)
10.2 Middle East & Africa AI in Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI in Biopharma Market Size by Country (2020-2025)
10.4 Middle East & Africa AI in Biopharma Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Recursion Pharmaceuticals
11.1.1 Recursion Pharmaceuticals Company Details
11.1.2 Recursion Pharmaceuticals Business Overview
11.1.3 Recursion Pharmaceuticals AI in Biopharma Introduction
11.1.4 Recursion Pharmaceuticals Revenue in AI in Biopharma Business (2020-2025)
11.1.5 Recursion Pharmaceuticals Recent Development
11.2 Exscientia
11.2.1 Exscientia Company Details
11.2.2 Exscientia Business Overview
11.2.3 Exscientia AI in Biopharma Introduction
11.2.4 Exscientia Revenue in AI in Biopharma Business (2020-2025)
11.2.5 Exscientia Recent Development
11.3 XtalPi
11.3.1 XtalPi Company Details
11.3.2 XtalPi Business Overview
11.3.3 XtalPi AI in Biopharma Introduction
11.3.4 XtalPi Revenue in AI in Biopharma Business (2020-2025)
11.3.5 XtalPi Recent Development
11.4 Schrödinger
11.4.1 Schrödinger Company Details
11.4.2 Schrödinger Business Overview
11.4.3 Schrödinger AI in Biopharma Introduction
11.4.4 Schrödinger Revenue in AI in Biopharma Business (2020-2025)
11.4.5 Schrödinger Recent Development
11.5 Owkin
11.5.1 Owkin Company Details
11.5.2 Owkin Business Overview
11.5.3 Owkin AI in Biopharma Introduction
11.5.4 Owkin Revenue in AI in Biopharma Business (2020-2025)
11.5.5 Owkin Recent Development
11.6 Evogene
11.6.1 Evogene Company Details
11.6.2 Evogene Business Overview
11.6.3 Evogene AI in Biopharma Introduction
11.6.4 Evogene Revenue in AI in Biopharma Business (2020-2025)
11.6.5 Evogene Recent Development
11.7 BioNTech
11.7.1 BioNTech Company Details
11.7.2 BioNTech Business Overview
11.7.3 BioNTech AI in Biopharma Introduction
11.7.4 BioNTech Revenue in AI in Biopharma Business (2020-2025)
11.7.5 BioNTech Recent Development
11.8 MedySapiens
11.8.1 MedySapiens Company Details
11.8.2 MedySapiens Business Overview
11.8.3 MedySapiens AI in Biopharma Introduction
11.8.4 MedySapiens Revenue in AI in Biopharma Business (2020-2025)
11.8.5 MedySapiens Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global AI in Biopharma Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Machine Learning (ML) & Deep Learning (DL)
Table 3. Key Players of Natural Language Processing (NLP)
Table 4. Key Players of Others
Table 5. Global AI in Biopharma Market Size Growth Rate by Research Direction (US$ Million): 2020 VS 2024 VS 2031
Table 6. Key Players of Drug Discovery & Development
Table 7. Key Players of Genomics & Precision Medicine
Table 8. Key Players of Medical Imaging & Diagnostics
Table 9. Key Players of Others
Table 10. Global AI in Biopharma Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global AI in Biopharma Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 12. Global AI in Biopharma Market Size by Region (2020-2025) & (US$ Million)
Table 13. Global AI in Biopharma Market Share by Region (2020-2025)
Table 14. Global AI in Biopharma Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 15. Global AI in Biopharma Market Share by Region (2026-2031)
Table 16. AI in Biopharma Market Trends
Table 17. AI in Biopharma Market Drivers
Table 18. AI in Biopharma Market Challenges
Table 19. AI in Biopharma Market Restraints
Table 20. Global AI in Biopharma Revenue by Players (2020-2025) & (US$ Million)
Table 21. Global AI in Biopharma Market Share by Players (2020-2025)
Table 22. Global Top AI in Biopharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Biopharma as of 2024)
Table 23. Ranking of Global Top AI in Biopharma Companies by Revenue (US$ Million) in 2024
Table 24. Global 5 Largest Players Market Share by AI in Biopharma Revenue (CR5 and HHI) & (2020-2025)
Table 25. Global Key Players of AI in Biopharma, Headquarters and Area Served
Table 26. Global Key Players of AI in Biopharma, Product and Application
Table 27. Global Key Players of AI in Biopharma, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global AI in Biopharma Market Size by Type (2020-2025) & (US$ Million)
Table 30. Global AI in Biopharma Revenue Market Share by Type (2020-2025)
Table 31. Global AI in Biopharma Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 32. Global AI in Biopharma Revenue Market Share by Type (2026-2031)
Table 33. Global AI in Biopharma Market Size by Application (2020-2025) & (US$ Million)
Table 34. Global AI in Biopharma Revenue Market Share by Application (2020-2025)
Table 35. Global AI in Biopharma Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 36. Global AI in Biopharma Revenue Market Share by Application (2026-2031)
Table 37. North America AI in Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. North America AI in Biopharma Market Size by Country (2020-2025) & (US$ Million)
Table 39. North America AI in Biopharma Market Size by Country (2026-2031) & (US$ Million)
Table 40. Europe AI in Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Europe AI in Biopharma Market Size by Country (2020-2025) & (US$ Million)
Table 42. Europe AI in Biopharma Market Size by Country (2026-2031) & (US$ Million)
Table 43. Asia-Pacific AI in Biopharma Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 44. Asia-Pacific AI in Biopharma Market Size by Region (2020-2025) & (US$ Million)
Table 45. Asia-Pacific AI in Biopharma Market Size by Region (2026-2031) & (US$ Million)
Table 46. Latin America AI in Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Latin America AI in Biopharma Market Size by Country (2020-2025) & (US$ Million)
Table 48. Latin America AI in Biopharma Market Size by Country (2026-2031) & (US$ Million)
Table 49. Middle East & Africa AI in Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 50. Middle East & Africa AI in Biopharma Market Size by Country (2020-2025) & (US$ Million)
Table 51. Middle East & Africa AI in Biopharma Market Size by Country (2026-2031) & (US$ Million)
Table 52. Recursion Pharmaceuticals Company Details
Table 53. Recursion Pharmaceuticals Business Overview
Table 54. Recursion Pharmaceuticals AI in Biopharma Product
Table 55. Recursion Pharmaceuticals Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)
Table 56. Recursion Pharmaceuticals Recent Development
Table 57. Exscientia Company Details
Table 58. Exscientia Business Overview
Table 59. Exscientia AI in Biopharma Product
Table 60. Exscientia Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)
Table 61. Exscientia Recent Development
Table 62. XtalPi Company Details
Table 63. XtalPi Business Overview
Table 64. XtalPi AI in Biopharma Product
Table 65. XtalPi Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)
Table 66. XtalPi Recent Development
Table 67. Schrödinger Company Details
Table 68. Schrödinger Business Overview
Table 69. Schrödinger AI in Biopharma Product
Table 70. Schrödinger Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)
Table 71. Schrödinger Recent Development
Table 72. Owkin Company Details
Table 73. Owkin Business Overview
Table 74. Owkin AI in Biopharma Product
Table 75. Owkin Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)
Table 76. Owkin Recent Development
Table 77. Evogene Company Details
Table 78. Evogene Business Overview
Table 79. Evogene AI in Biopharma Product
Table 80. Evogene Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)
Table 81. Evogene Recent Development
Table 82. BioNTech Company Details
Table 83. BioNTech Business Overview
Table 84. BioNTech AI in Biopharma Product
Table 85. BioNTech Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)
Table 86. BioNTech Recent Development
Table 87. MedySapiens Company Details
Table 88. MedySapiens Business Overview
Table 89. MedySapiens AI in Biopharma Product
Table 90. MedySapiens Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)
Table 91. MedySapiens Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
Table 95. Authors List of This Report


List of Figures
Figure 1. AI in Biopharma Picture
Figure 2. Global AI in Biopharma Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global AI in Biopharma Market Share by Type: 2024 VS 2031
Figure 4. Machine Learning (ML) & Deep Learning (DL) Features
Figure 5. Natural Language Processing (NLP) Features
Figure 6. Others Features
Figure 7. Global AI in Biopharma Market Size Comparison by Research Direction (2020-2031) & (US$ Million)
Figure 8. Drug Discovery & Development Features
Figure 9. Genomics & Precision Medicine Features
Figure 10. Medical Imaging & Diagnostics Features
Figure 11. Others Features
Figure 12. Global AI in Biopharma Market Size by Application (2020-2031) & (US$ Million)
Figure 13. Global AI in Biopharma Market Share by Application: 2024 VS 2031
Figure 14. Drug Development Case Studies
Figure 15. Disease Diagnosis and Treatment Case Studies
Figure 16. Other Case Studies
Figure 17. AI in Biopharma Report Years Considered
Figure 18. Global AI in Biopharma Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global AI in Biopharma Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global AI in Biopharma Market Share by Region: 2024 VS 2031
Figure 21. Global AI in Biopharma Market Share by Players in 2024
Figure 22. Global AI in Biopharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. The Top 10 and 5 Players Market Share by AI in Biopharma Revenue in 2024
Figure 24. North America AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America AI in Biopharma Market Share by Country (2020-2031)
Figure 26. United States AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe AI in Biopharma Market Share by Country (2020-2031)
Figure 30. Germany AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Ireland AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific AI in Biopharma Market Share by Region (2020-2031)
Figure 38. China AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia & New Zealand AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America AI in Biopharma Market Share by Country (2020-2031)
Figure 46. Mexico AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa AI in Biopharma Market Share by Country (2020-2031)
Figure 50. Israel AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Recursion Pharmaceuticals Revenue Growth Rate in AI in Biopharma Business (2020-2025)
Figure 54. Exscientia Revenue Growth Rate in AI in Biopharma Business (2020-2025)
Figure 55. XtalPi Revenue Growth Rate in AI in Biopharma Business (2020-2025)
Figure 56. Schrödinger Revenue Growth Rate in AI in Biopharma Business (2020-2025)
Figure 57. Owkin Revenue Growth Rate in AI in Biopharma Business (2020-2025)
Figure 58. Evogene Revenue Growth Rate in AI in Biopharma Business (2020-2025)
Figure 59. BioNTech Revenue Growth Rate in AI in Biopharma Business (2020-2025)
Figure 60. MedySapiens Revenue Growth Rate in AI in Biopharma Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies